Skip to main content

Structure Therapeutics Inc.

GPCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001888886

No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.

Members of Congress who traded GPCR

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
0 / 1
Estimated volume
$8.00K
Sum of range midpoints
Members of Congress who traded GPCR
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Thomas R. CarperDemocrat · Senate · DE10 / 1$8.00KOct 4, 2023Nov 2, 2023

Trades

Every reported trade in Structure Therapeutics Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Thomas R. CarperDemocrat · Senate · DEGPCRStructure Therapeutics IncSell (full)SpouseOct 4, 2023Nov 2, 202329 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.